Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Frey

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
Nuclear Medicine and Biology|February 5, 2013
Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635Andreas Hahn, Lukas Nics, Pia Baldinger, et al.
Frontiers in Psychiatry|July 19, 2023
Case report: Interstitial pneumonitis after initiation of lamotrigineVictoria Watzal, Godber Mathis Godbersen, Ana Weidenauer, et al.
The International Journal of Neuropsychopharmacology|June 7, 2026
Secondary Restless Legs Syndrome during Psychopharmacological Treatment: Real-World Evidence from a Multinational Pharmacovigilance ProgramGernot Fugger, Ulrich Rabl, Lucie Bartova, et al.
Translational Psychiatry|January 19, 2024
Effects of lockdowns on neurobiological and psychometric parameters in unipolar depression during the COVID-19 pandemicJakob Unterholzner, Alexander Kautzky, Murray Bruce Reed, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2026
Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study"Andreas Reif, A Elif Anıl Yağcıoğlu, Istvan Bitter, et al.
The New England Journal of Medicine|October 4, 2023
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant DepressionAndreas Reif, Istvan Bitter, Jozefien Buyze, et al.
Brain Stimulation|January 13, 2019
The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomographyPia Baldinger-Melich, Gregor Gryglewski, Cécile Philippe, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
Nuclear Medicine and Biology|February 5, 2013
Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635Andreas Hahn, Lukas Nics, Pia Baldinger, et al.
Frontiers in Psychiatry|July 19, 2023
Case report: Interstitial pneumonitis after initiation of lamotrigineVictoria Watzal, Godber Mathis Godbersen, Ana Weidenauer, et al.
The International Journal of Neuropsychopharmacology|June 7, 2026
Secondary Restless Legs Syndrome during Psychopharmacological Treatment: Real-World Evidence from a Multinational Pharmacovigilance ProgramGernot Fugger, Ulrich Rabl, Lucie Bartova, et al.
Translational Psychiatry|January 19, 2024
Effects of lockdowns on neurobiological and psychometric parameters in unipolar depression during the COVID-19 pandemicJakob Unterholzner, Alexander Kautzky, Murray Bruce Reed, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 5, 2026
Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study"Andreas Reif, A Elif Anıl Yağcıoğlu, Istvan Bitter, et al.
The New England Journal of Medicine|October 4, 2023
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant DepressionAndreas Reif, Istvan Bitter, Jozefien Buyze, et al.
Brain Stimulation|January 13, 2019
The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomographyPia Baldinger-Melich, Gregor Gryglewski, Cécile Philippe, et al.
Pageof 5